J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
强生:许可新型口服资产,进一步加强对特应性皮炎的承诺
J&J: To License Novel Oral Assets, Further Strengthening Commitment to Atopic Dermatitis
强生:许可新型口服资产,进一步加强对特应性皮炎的承诺
使用浏览器的分享功能,分享给你的好友吧